A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : ARB

Search Conditions:
Search Keyword : ARB
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: ARB
Appearance Frequency: 2475 time(s)
Long forms: 84

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
angiotensin receptor blocker
(1866 times)
Vascular Diseases
(398 times)
ACEI (761 times)
ACE (298 times)
BP (230 times)
1999 Comparative antihypertensive effects of angiotensin II receptor antagonists.
antibiotic resistant bacteria
(256 times)
Environmental Health
(183 times)
ARGs (147 times)
ARG (21 times)
WWTPs (21 times)
2003 Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference?
autosomal recessive bestrophinopathy
(50 times)
Ophthalmology
(28 times)
BVMD (12 times)
EOG (12 times)
BEST1 (10 times)
2008 Biallelic mutation of BEST1 causes a distinct retinopathy in humans.
anode-respiring bacteria
(43 times)
Environmental Health
(15 times)
MEC (6 times)
MFCs (6 times)
BES (5 times)
2008 Evaluation of energy-conversion efficiencies in microbial fuel cells (MFCs) utilizing fermentable and non-fermentable substrates.
Ang II receptor blocker
(35 times)
Vascular Diseases
(8 times)
Ang II (12 times)
BP (9 times)
ACEI (8 times)
2000 New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease.
Acid Red B
(21 times)
Environmental Health
(14 times)
AS (3 times)
DRS (2 times)
SMF (2 times)
2003 [Study on electrochemical degradation of acid red B(ARB)].
accumulative roll-bonding
(20 times)
Nanotechnology
(11 times)
DLPC (4 times)
FESEM (2 times)
OFC (2 times)
2006 Annealing characteristics of nano-grained oxygen free copper processed by accumulative roll-bonding process.
antimicrobial-resistant bacteria
(20 times)
Communicable Diseases
(4 times)
ARGs (7 times)
MDR (3 times)
ESBL (2 times)
2012 Novel antimicrobial-resistant bacteria among patients requiring chronic hemodialysis.
amoeba-resistant bacteria
(18 times)
Microbiology
(9 times)
FLA (7 times)
AM (1 time)
AMR (1 time)
2001 [Effectiveness of WHO strategies in prisons in the Ivanovsk district].
10  Arbidol
(12 times)
Virology
(7 times)
HCV (4 times)
CHIKV (1 time)
COVID-19 (1 time)
2006 Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection.
11  Air Resources Board
(10 times)
Environmental Health
(9 times)
MY (2 times)
PEMS (2 times)
PM (2 times)
1991 An analysis of biomedical waste incineration.
12  AT1-R blockers
(8 times)
Nephrology
(2 times)
AT1R (3 times)
ACEI (2 times)
Ang II (2 times)
2005 An extremely high dose of losartan affords superior renoprotection in the remnant model.
13  arbutin
(7 times)
Drug Therapy
(1 time)
ATRP (2 times)
MMA (2 times)
Vit C (2 times)
2015 On the pharmacology of oxidative burst of human neutrophils.
14  Athabasca River Basin
(7 times)
Environmental Health
(6 times)
SWAT (5 times)
PDO (2 times)
AMO (1 time)
2015 Long-term reliability of the Athabasca River (Alberta, Canada) as the water source for oil sands mining.
15  Acid-resistant bacilli
(6 times)
Microbiology
(3 times)
LJ (3 times)
EZN (2 times)
MOTT (2 times)
2007 [Isolation and identification of Mycobacterium tuberculosis from the urine samples by conventional and molecular methods].
16  abnormal repetitive behavior
(4 times)
Veterinary Medicine
(1 time)
ARL (1 time)
2011 Recurrent perseveration correlates with abnormal repetitive locomotion in adult mink but is not reduced by environmental enrichment.
17  aged-refuse bioreactor
(4 times)
Environmental Health
(3 times)
BOD (1 time)
COD (1 time)
DE (1 time)
2007 Treatment of landfill leachate by combined aged-refuse bioreactor and electro-oxidation.
18  angiotensin blocker
(4 times)
Medicine
(2 times)
ACEI (1 time)
BP (1 time)
Cr (1 time)
2006 Combined treatment with valsartan and spironolactone prevents cardiovascular remodeling in renovascular hypertensive rats.
19  Athens Randombreds
(4 times)
Veterinary Medicine
(4 times)
AC (2 times)
ACRB (1 time)
1976 Modification of corticosterone and glucose responses by sympatholytic agents in young chickens during acute heat exposure.
20  Administrative Review Board
(3 times)
Jurisprudence
(3 times)
ALJ (3 times)
OSHA (3 times)
IFR (2 times)
2013 Procedures for the handling of retaliation complaints under section 1558 of the Affordable Care Act. Interim final rule; request for comments.
21  alkali-revealed breaks
(3 times)
Radiology
(2 times)
FSB (3 times)
DS (1 time)
1994 Radiolytic signature of Z-DNA.
22  aortorenal bypass
(3 times)
General Surgery
(3 times)
TARAS (2 times)
DDD (1 time)
DR (1 time)
2010 Surgical treatment and long-term outcome of renovascular hypertension in children and adolescents.
23  Arbidol hydrochloride
(3 times)
Medicine
(1 time)
HSV-1 (1 time)
p.i (1 time)
2013 Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection.
24  area of reduced birefringence
(3 times)
Cell Biology
(3 times)
--- 1983 Action spectrum for changes in spindle fibre birefringence after ultraviolet microbeam irradiations of single chromosomal spindle fibres in crane-fly spermatocytes.
25  angiogenesis-related blindness
(2 times)
Pharmacology
(2 times)
--- 2013 Nanoparticles in the treatment of angiogenesis-related blindness.
26  angiotensin II receptor type I blocker
(2 times)
Cardiology
(2 times)
HSF2 (1 time)
HSFs (1 time)
I/R (1 time)
2013 Effects of the novel angiotensin II receptor type I antagonist, fimasartan on myocardial ischemia/reperfusion injury.
27  arabinogalactan
(2 times)
Chemistry
(1 time)
NPs (1 time)
2010 Light scattering from aqueous solutions of colloid metal nanoparticles stabilized by natural polysaccharide arabinogalactan.
28  Arbia
(2 times)
Tropical Medicine
(1 time)
TOS (2 times)
TOT (1 time)
1988 [Virus transmission to man from Phlebotomus flies: role of the Tuscany virus (Bunyaviridae, Phlebovirus) in the etiology of infections of the central nervous system].
29  average relative binding
(2 times)
Allergy and Immunology
(2 times)
MHC (2 times)
HLAs (1 time)
2005 Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.
30  aberrant reticulate body
(1 time)
Proteome
(1 time)
EB (1 time)
RB (1 time)
2016 Quantitative Protein Profiling of Chlamydia trachomatis Growth Forms Reveals Defense Strategies Against Tryptophan Starvation.
31  absolute risk benefit
(1 time)
Neurology
(1 time)
ARH (1 time)
2013 The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects.
32  ABSTRACT
(1 time)
Medicine
(1 time)
MSDBP (1 time)
MSSBP (1 time)
2009 Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy.
33  access-related BSI
(1 time)
Natural Science Disciplines
(1 time)
BSI (1 time)
HD (1 time)
LASI (1 time)
2017 Surveillance of Dialysis Events: one-year experience at 33 outpatient hemodialysis centers in China.
34  Activated red brick
(1 time)
Natural Science Disciplines
(1 time)
1,5-PDO (1 time)
1,6-HDO (1 time)
OP (1 time)
2019 Unique Lewis and Bronsted acidic sites texture in the selective production of tetrahydropyran and oxepanefrom1,5-pentanediol and 1,6-hexanediol over sustainable red brick clay catalyst.
35  activation of MAPKs were inhibited with AT I receptor antagonist
(1 time)
Biochemistry
(1 time)
ERK (1 time)
FN (1 time)
MAPKs (1 time)
2003 Possible involvement of mitogen-activated protein kinase in the angiotensin II-induced fibronectin synthesis in renal interstitial fibroblasts.
36  active retrograde backup
(1 time)
Cardiology
(1 time)
CC (1 time)
CTO (1 time)
PCI (1 time)
2020 Active Retrograde Extra Backup with a Mother-and-Child Catheter to Facilitate Retrograde Microcatheter Collateral Channel Tracking in Recanalization of Coronary Chronic Total Occlusion.
37  acute reduction in buoyancy
(1 time)
Neurology
(1 time)
AR (1 time)
EMG (1 time)
2001 Age-related changes and condition-dependent modifications in distribution of limb movements during embryonic motility.
38  administration of ACE inhibitors, All antagonists
(1 time)
Internal Medicine
(1 time)
--- 2011 [Pharmacotherapy of chronic heart failure after the first decade of 21st century].
39  adolescents engaging in risky behaviors
(1 time)
Pediatrics
(1 time)
ASHCN (1 time)
2002 Health care use and charges for adolescents enrolled in a title XXI program.
40  aged refuse-based bioreactor
(1 time)
Environmental Health
(1 time)
AOPs (1 time)
MSW (1 time)
2017 Coupling ARB-based biological and photochemical (UV/TiO2 and UV/S2O82-) techniques to deal with sanitary landfill leachate.
41  aged refuse-based bioreactor/biofilter
(1 time)
Biotechnology
(1 time)
MSW (1 time)
2014 Use of aged refuse-based bioreactor/biofilter for landfill leachate treatment.
42  aim is to study Irbesartan
(1 time)
Nephrology
(1 time)
ACEI (1 time)
ACKD (1 time)
BP (1 time)
2008 [Irbesartan in hypertensive non-diabetic advanced chronic kidney disease. Comparative study with ACEI].
43  Air Re-bubbling
(1 time)
BK (1 time)
DSAEK (1 time)
FD (1 time)
2020 Graft Detachment After Descemet's Stripping Automated Endothelial Keratoplasty in Bullous Keratopathy and Fuchs Dystrophy.
44  aldosterone receptorblockers
(1 time)
Cardiology
(1 time)
ACEI (1 time)
2020 Impact of Treatment with Renin-Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19.
45  alone or in combination with tempol, enalapril, or valsartan
(1 time)
Cardiology
(1 time)
ACh (1 time)
NO (1 time)
NTG (1 time)
2007 Evaluation of pharmacological modulation of nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor.
46  alternating rungs birdcage
(1 time)
Diagnostic Imaging
(1 time)
FRB (1 time)
MRI (1 time)
RU (1 time)
2015 Optimization and comparison of two practical dual-tuned birdcage configurations for quantitative assessment of articular cartilage with sodium magnetic resonance imaging.
47  Amazon River Basin
(1 time)
Environmental Health
(1 time)
YLS (1 time)
2020 Conserving the Amazon River Basin: The case study of the Yahuarcaca Lakes System in Colombia.
48  amorphous reticular bodies
(1 time)
Gastroenterology
(1 time)
FDI (1 time)
1990 Watching fat digestion: a microscopic method assessing intraluminal lipolysis.
49  amphiphilic rose bengal
(1 time)
Biocompatible Materials
(1 time)
RB-MBs (1 time)
ROS (1 time)
SDT (1 time)
2020 In situ conversion of rose bengal microbubbles into nanoparticles for ultrasound imaging guided sonodynamic therapy with enhanced antitumor efficacy.
50  AMR bacteria
(1 time)
Tropical Medicine
(1 time)
AMR (1 time)
ARGs (1 time)
2020 The Contribution of Wastewater to the Transmission of Antimicrobial Resistance in the Environment: Implications of Mass Gathering Settings.
51  androgen receptor blockade
(1 time)
Nuclear Medicine
(1 time)
BIC (1 time)
CR (1 time)
ENZ (1 time)
2018 Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer.
52  angiotensin II receptor inhibitor
(1 time)
Medicine
(1 time)
ACEI (1 time)
PCI (1 time)
STEMI (1 time)
2007 Impact of gender on treatment and clinical outcomes in acute ST elevation myocardial infarction patients in Thailand.
53  Angiotensin II type 1 receptor blocker L-158,809
(1 time)
Cardiology
(1 time)
HYD (1 time)
LV (1 time)
SHHF (1 time)
2006 p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats.
54  angiotensin II type 1-receptor blocking agents
(1 time)
Vascular Diseases
(1 time)
ACE (1 time)
RAS (1 time)
2002 Use of angiotensin II receptor blockers in animal models of atherosclerosis.
55  angiotensin-converting enzyme inhibitor(ACEI)/angiotensin II receptor antagonists
(1 time)
Pediatrics
(1 time)
ACEI (1 time)
2013 [Multicenter investigation of therapeutic status of children with IgA nephropathy in China].
56  angiotensin-ll receptor blocker candesartan
(1 time)
Vascular Diseases
(1 time)
cap (1 time)
CCB (1 time)
ISP (1 time)
2005 Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure.
57  angiotensin-releasing blocker
(1 time)
Transplantation
(1 time)
IS (1 time)
Srl (1 time)
2008 Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients.
58  Annona reticulata bark
(1 time)
Neurosciences
(1 time)
ZJ (1 time)
2017 Bioactive Fraction of Annona reticulata Bark (or) Ziziphus jujuba Root Bark along with Insulin Attenuates Painful Diabetic Neuropathy through Inhibiting NF-kappaB Inflammatory Cascade.
59  annuloplasty ring base
(1 time)
General Surgery
(1 time)
AB (1 time)
CT (1 time)
2017 An Expansible Aortic Ring in Aortic Root Remodeling: Exact Position, Pulsatility, Effectiveness, and Stability in Three-Dimensional CT Study.
60  another angiotensin II receptor blocker
(1 time)
Clinical Medicine
(1 time)
BPV (1 time)
2017 Effect of Azilsartan on Day-to-Day Variability in Home Blood Pressure: A Prospective Multicenter Clinical Trial.
61  Anti-reflux barrier
(1 time)
General Surgery
(1 time)
GER (1 time)
GYP (1 time)
GYV (1 time)
2013 Gastric yield pressure and gastric yield volume to assess anti-reflux barrier in a porcine model.
62  Antibiotic Residue Branch
(1 time)
Environmental Health
(1 time)
IDF-AOAC (1 time)
1984 Comparison of Microbiological Methods for Detecting Penicillin and Penicillin-Like Antibiotic Residues in Milk.
63  antihypertensive angiotensin II receptor blocker
(1 time)
Cardiology
(1 time)
QYHJ (1 time)
2013 Cardioankle vascular index evaluations revealed that cotreatment of ARB Antihypertension medication with traditional Chinese medicine improved arterial functionality.
64  Appetitive risk behaviors
(1 time)
Psychology
(1 time)
--- 2020 The role of incidental affective states in appetitive risk behavior: A meta-analysis.
65  ARB MED trial
(1 time)
Vascular Diseases
(1 time)
ES (1 time)
2018 Intense aerobic exercise lowers blood pressure in individuals with metabolic syndrome taking antihypertensive medicine.
66  arbekacin
(1 time)
Anti-Bacterial Agents
(1 time)
DAP (1 time)
LIN (1 time)
MRSA (1 time)
2005 Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.
67  Arbequina
(1 time)
Botany
(1 time)
AZ (1 time)
AZ-AC (1 time)
ET (1 time)
2011 Polyamine-induced modulation of genes involved in ethylene biosynthesis and signalling pathways and nitric oxide production during olive mature fruit abscission.
68  arbitrary day and night time intervals
(1 time)
Vascular Diseases
(1 time)
ABP (1 time)
ACT (1 time)
BP (1 time)
1997 Blood pressure during siesta: effect on 24-h ambulatory blood pressure profiles analysis.
69  arbitrary facial movements
(1 time)
Neurology
(1 time)
OTHER (1 time)
2006 Being with virtual others: Neural correlates of social interaction.
70  aromatic bonds
(1 time)
Computational Biology
(1 time)
HBA (1 time)
HBD (1 time)
ROB (1 time)
2011 A Comparative Study on the Constitutive Properties of Marketed Pesticides.
71  Asopos River Basin
(1 time)
Environmental Health
(1 time)
CE (1 time)
WTP (1 time)
2017 Do agents' characteristics affect their valuation of 'common pool' resources? A full-preference ranking analysis for the value of sustainable river basin management.
72  association with angiotensin II type I blockers
(1 time)
Patient Care
(1 time)
BCPNN (1 time)
ED (1 time)
IC (1 time)
2010 Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers.
73  asthma, rhinobronchitis
(1 time)
Allergy and Immunology
(1 time)
AR (1 time)
2007 Effect of allergic rhinitis, asthma and rhinobronchitis on dental malocclusion in adolescents.
74  atherosclerosis, to respond to ACE inhibitor or Ang II antagonist
(1 time)
Pharmacology
(1 time)
ACE (1 time)
Ang II (1 time)
RAS (1 time)
2006 Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase.
75  atypical residual bodies
(1 time)
Embryology
(1 time)
DBAA (1 time)
1997 Histopathologic changes in the testes of rats exposed to dibromoacetic acid.
76  Australian Racing Board
(1 time)
Medicine
(1 time)
--- 2011 An investigation of racing performance and whip use by jockeys in thoroughbred races.
77  average relative bias
(1 time)
Biophysics
(1 time)
LCA (1 time)
LIDC (1 time)
2010 Assessing operating characteristics of CAD algorithms in the absence of a gold standard.
78  beta-adrenergic blockers
(1 time)
Pharmacology
(1 time)
ACEI (1 time)
CCB (1 time)
2014 What role does African ancestry play in how hypertensive patients respond to certain antihypertensive drug therapy?
79  beta1-adrenoreceptor blockers
(1 time)
Pediatrics
(1 time)
ACEI (1 time)
BLS (1 time)
HF (1 time)
2019 Pediatric heart failure therapy: why beta1-receptor blocker, tissue ACE-I and mineralocorticoid-receptor-blocker?
80  biotype-antibiotic resistogram
(1 time)
Microbiology
(1 time)
CNS (1 time)
1992 Ribotyping of coagulase-negative staphylococci.
81  radicals-to-alkali-revealed breaks
(1 time)
Radiology
(1 time)
FSB (1 time)
1999 Monte Carlo simulation of radiolytic attack to 5'-d[T4G4]4 sequence in a unimolecular quadruplex.
82  ribosomal antigens
(1 time)
Allergy and Immunology
(1 time)
LBV (1 time)
1986 Immunotherapy with standard bacterial and bacterial ribosomal antigens in childhood bronchial asthma.
83  ss1-adrenergic receptor blocker
(1 time)
Pediatrics
(1 time)
ACEI (1 time)
CHF (1 time)
DCM (1 time)
2016 "Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld.
84  three-stage-aged refuse bioreactor
(1 time)
Environmental Health
(1 time)
BFC (1 time)
BOD (1 time)
COD (1 time)
2009 Hydrophobic organic chemicals (HOCs) removal from biologically treated landfill leachate by powder-activated carbon (PAC), granular-activated carbon (GAC) and biomimetic fat cell (BFC).